Search results: Sage Journals

Free accessResearch articleFirst published July, 2016

Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis

Sandip Chaugai, Wen Yeng Meng, Amir Ali Sepehry

Journal of Cardiovascular Pharmacology and Therapeutics

Open accessResearch articleFirst published September, 2015

Effect of angiotensin II receptor blockers,candesartan,on osteoprotegerin level in hypertensive patients: Link between bone and RAAS

H Oz, D Gavish, A Hass [...]

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published March, 2004

Conclusions on the management of heart failure

Karl Swedberg

Journal of the Renin-Angiotensin-Aldosterone System

Free accessReview articleFirst published August, 2015

Combination use of medicines from two classes of renin–angiotensin system blocking agents: risk of hyperkalemia,hypotension,and impaired renal function

Raquel Esteras, Maria Vanessa Perez-Gomez, Laura Rodriguez-Osorio [...]

Therapeutic Advances in Drug Safety

Open accessResearch articleFirst published 2021

Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis

Upinder Kaur, Sankha Shubhra Chakrabarti, Tejas K. Patel

Therapeutic Advances in Drug Safety

Restricted accessOtherFirst published March, 2012

Cardiorenal disease development under chronic renin–angiotensin–aldosterone system suppression

Pantelis A Sarafidis, Luis M Ruilope

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published August, 2005

Assessment of Prescriber Compliance with Established Heart Failure Guidelines at a Major Medical Center

Kyle A Weant, Kelly M. Smith, Daniel A. Lewis

Hospital Pharmacy

Free accessResearch articleFirst published May, 2013

Is there benefit in dual renin– angiotensin–aldosterone system blockade? No,yes and maybe: A guide for the perplexed

Jencia Wong

Diabetes & Vascular Disease Research

Free accessReview articleFirst published December, 2010

Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends

Nageshwara Gullapalli, Michael J. Bloch, Jan Basile

Therapeutic Advances in Cardiovascular Disease

Open accessResearch articleFirst published 2016

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers

Yuichiro Ueda, Hiroki Ishii, Taisuke Kitano [...]

Drug Target Insights

Free accessResearch articleFirst published July, 2016

Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis

Sandip Chaugai, Wen Yeng Meng, Amir Ali Sepehry

Journal of Cardiovascular Pharmacology and Therapeutics

Open accessResearch articleFirst published September, 2015

Effect of angiotensin II receptor blockers,candesartan,on osteoprotegerin level in hypertensive patients: Link between bone and RAAS

H Oz, D Gavish, A Hass [...]

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published March, 2004

Conclusions on the management of heart failure

Karl Swedberg

Journal of the Renin-Angiotensin-Aldosterone System

Free accessReview articleFirst published August, 2015

Combination use of medicines from two classes of renin–angiotensin system blocking agents: risk of hyperkalemia,hypotension,and impaired renal function

Raquel Esteras, Maria Vanessa Perez-Gomez, Laura Rodriguez-Osorio [...]

Therapeutic Advances in Drug Safety

Open accessResearch articleFirst published 2021

Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis

Upinder Kaur, Sankha Shubhra Chakrabarti, Tejas K. Patel

Therapeutic Advances in Drug Safety

Restricted accessOtherFirst published March, 2012

Cardiorenal disease development under chronic renin–angiotensin–aldosterone system suppression

Pantelis A Sarafidis, Luis M Ruilope

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published August, 2005

Assessment of Prescriber Compliance with Established Heart Failure Guidelines at a Major Medical Center

Kyle A Weant, Kelly M. Smith, Daniel A. Lewis

Hospital Pharmacy

Free accessResearch articleFirst published May, 2013

Is there benefit in dual renin– angiotensin–aldosterone system blockade? No,yes and maybe: A guide for the perplexed

Jencia Wong

Diabetes & Vascular Disease Research

Free accessReview articleFirst published December, 2010

Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends

Nageshwara Gullapalli, Michael J. Bloch, Jan Basile

Therapeutic Advances in Cardiovascular Disease

Open accessResearch articleFirst published 2016

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers

Yuichiro Ueda, Hiroki Ishii, Taisuke Kitano [...]

Drug Target Insights